DIN 02556812 — OPFOLDA 65 MG
OPFOLDA is a capsule of Miglustat marketed by AMICUS THERAPEUTICS CANADA INC.. The full Miglustat monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02556812
- Brand name
- OPFOLDA
- Active ingredient
- Miglustat
- Strength
- 65 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- AMICUS THERAPEUTICS CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Glucosylceramide synthase inhibitor (substrate reduction therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Miglustat products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02456257 | SANDOZ MIGLUSTAT | 100 MG | CAPSULE | SANDOZ CANADA INCORPORATED | MARKETED |
| 02250519 | ZAVESCA | 100 MG | CAPSULE | JANSSEN INC | MARKETED |